No paralogue variants have been mapped to residue 437 for SCN5A.
| SCN5A | ILAVVAMAYEEQNQATIAETEEK-EKRFQE>A<MEMLKK------------EHEALTIRGVDT | 455 |
| SCN1A | ILAVVAMAYEEQNQATLEEAEQK-EAEFQQ>M<IEQLKK------------QQEAAQQAATAT | 465 |
| SCN2A | ILAVVAMAYEEQNQATLEEAEQK-EAEFQQ>M<LEQLKK------------QQEEAQAAAAAA | 467 |
| SCN3A | ILAVVAMAYEEQNQATLEEAEQK-EAEFQQ>M<LEQLKK------------QQEEAQAVAAAS | 466 |
| SCN4A | ILAVVAMAYAEQNEATLAEDKEK-EEEFQQ>M<LEKFKK------------HQEELEKAKAAQ | 489 |
| SCN7A | FLGILAMAYEEEKQRVGEISKKI-EPKFQQ>T<GKELQE------------GNETDEAK---- | 432 |
| SCN8A | ILAVVAMAYEEQNQATLEEAEQK-EAEFKA>M<LEQLKK------------QQEEAQAAAMAT | 453 |
| SCN9A | ILAVVAMAYEEQNQANIEEAKQK-ELEFQQ>M<LDRLKK------------EQEEAEAIAAAA | 444 |
| SCN10A | ILAVVTMAYEEQNQATTDEIEAK-EKKFQE>A<LEMLRK------------EQEVLAALGIDT | 439 |
| SCN11A | TLAVVTMAYEEQNKNVAAEIEAK-EKMFQE>A<QQLLKE------------EKEALVAMGIDR | 442 |
| CACNA1A | VLGVLSGEFAKERERVENRRAFLKLRRQQQ>I<ERELNG------------YMEWISKA-EE- | 401 |
| CACNA1B | VLGVLSGEFAKERERVENRRAFLKLRRQQQ>I<ERELNG------------YLEWIFKA-EE- | 397 |
| CACNA1C | VLGVLSGEFSKEREKAKARGDFQKLREKQQ>L<EEDLKG------------YLDWITQA-ED- | 446 |
| CACNA1D | VLGVLSGEFSKEREKAKARGDFQKLREKQQ>L<EEDLKG------------YLDWITQA-ED- | 447 |
| CACNA1E | VLGVLSGEFAKERERVENRRAFMKLRRQQQ>I<ERELNG------------YRAWIDKA-EE- | 392 |
| CACNA1F | VLGVLSGEFSKEREKAKARGDFQKQREKQQ>M<EEDLRG------------YLDWITQA-EE- | 413 |
| CACNA1G | CLVVIATQFSETKQRESQLMREQRVRFLSN>A<STLASFSEPGSCYEELLKYLVYILRKAAR- | 449 |
| CACNA1H | CLVVIATQFSETKQRESQLMREQRARHLSN>D<STLASFSEPGSCYEELLKYVGHIFRKVKR- | 473 |
| CACNA1I | CLVVIATQFSETKQREHRLMLEQRQRYLS->S<STVASYAEPGDCYEEIFQYVCHILRKAKR- | 451 |
| CACNA1S | VLGVLSGEFTKEREKAKSRGTFQKLREKQQ>L<DEDLRG------------YMSWITQG-EV- | 375 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.A437V | c.1310C>T | Putative Benign | SIFT: Polyphen: |